The FASEB Journal, Vol 9, 504-508, Copyright © 1995 by The Federation of American Societies for Experimental Biology

REVIEWS

Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm

FL Lorscheider, MJ Vimy and AO Summers
Department of Medical Physiology, Faculty of Medicine, University of Calgary, Alberta, Canada.

For more than 160 years dentistry has used silver amalgam, which contains approximately 50% Hg metal, as the preferred tooth filling material. During the past decade medical research has demonstrated that this Hg is continuously released as vapor into mouth air; then it is inhaled, absorbed into body tissues, oxidized to ionic Hg, and finally covalently bound to cell proteins. Animal and human experiments demonstrate that the uptake, tissue distribution, and excretion of amalgam Hg is significant, and that dental amalgam is the major contributing source to Hg body burden in humans. Current research on the pathophysiological effects of amalgam Hg has focused upon the immune system, renal system, oral and intestinal bacteria, reproductive system, and the central nervous system. Research evidence does not support the notion of amalgam safety.

This article has been cited by other articles:

				G Guzzi and P D Pigatto Occupational exposure to mercury from amalgams during pregnancy Occup. Environ. Med., October 1, 2007; 64(10): 715 - 716. [Full Text] [PDF]

				H. L. Needleman Mercury in dental amalgam--a neurotoxic risk? JAMA, April 19, 2006; 295(15): 1835 - 1836. [Full Text] [PDF]

				G Hansen, R Victor, E Engeldinger, and C Schweitzer Evaluation of the mercury exposure of dental amalgam patients by the Mercury Triple Test Occup. Environ. Med., June 1, 2004; 61(6): 535 - 540. [Abstract] [Full Text]

				R. J. Billings, R. J. Berkowitz, and G. Watson Teeth Pediatrics, April 1, 2004; 113(4/S1): 1120 - 1127. [Abstract] [Full Text] [PDF]

				M. Plante, S. Babo, J. Mutter, J. Naumann, C. Buettner, E. Guallar, R. A. Riemersma, F. J. Kok, K. Yoshizawa, E. B. Rimm, et al. Mercury and the Risk of Myocardial Infarction N. Engl. J. Med., May 22, 2003; 348(21): 2151 - 2154. [Full Text] [PDF]

				A. Gupta, L. T. Phung, D. E. Taylor, and S. Silver Diversity of silver resistance genes in IncH incompatibility group plasmids Microbiology, December 1, 2001; 147(12): 3393 - 3402. [Abstract] [Full Text] [PDF]

				F. Lorscheider and M. Vimy Mercury and idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., March 1, 2000; 35(3): 819 - 819. [Full Text] [PDF]

				H. V. Aposhian, A. Arroyo, M. E. Cebrian, L. M. Del Razo, K. M. Hurlbut, R. C. Dart, D. Gonzalez-Ramirez, H. Kreppel, H. Speisky, A. Smith, et al. DMPS-Arsenic Challenge Test. I: Increased Urinary Excretion of Monomethylarsonic Acid in Humans Given Dimercaptopropane Sulfonate J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 192 - 200. [Abstract] [Full Text]